Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in human artificial chromosome technology.

Zoia Larin1, José E Mejía

  • 1Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. zlarin@molbiol.ox.ac.uk

Trends in Genetics : TIG
|June 5, 2002
PubMed
Summary

Human artificial chromosomes (HACs) are advancing as gene transfer vectors for expression studies and understanding chromosome function. This technology enables the transfer of large genomic loci for gene complementation and expressing human transgenes in animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Separation of the Ca<sub>V</sub> 1.2-Ca<sub>V</sub> 1.3 calcium channel duo prevents type 2 allergic airway inflammation.

Allergy·2021
Same author

Stablity of yellow fever virus neutralising antibody titres - Authors' reply.

The Lancet. Infectious diseases·2020
Same author

Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study.

The Lancet. Infectious diseases·2019
Same author

Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Seminars in immunopathology·2018
Same author

<i>TLR7</i> escapes X chromosome inactivation in immune cells.

Science immunology·2018
Same author

SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.

Molecular therapy : the journal of the American Society of Gene Therapy·2010

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Biotechnology

Background:

  • Human artificial chromosome (HAC) technology has seen significant advancements in recent years.
  • HACs are increasingly recognized for their utility in gene transfer and functional genomics.

Purpose of the Study:

  • To highlight the recent developments and applications of HAC technology.
  • To underscore the role of HACs in gene expression studies and determining human chromosome function.
  • To showcase the potential of HACs for complementing gene deficiencies and expressing large transgenes in animal models.

Main Methods:

  • Utilizing HACs as vectors for gene transfer.
  • Employing HACs for the complementation of gene deficiencies in human cultured cells.
  • Applying HACs for the expression of large human transgenes in animal models, particularly mouse models of genetic diseases.

Related Experiment Videos

Main Results:

  • HACs have proven effective as gene transfer vectors in expression studies.
  • HACs are valuable tools for elucidating human chromosome function.
  • HAC technology facilitates the transfer of large genomic loci with regulatory elements for proper gene expression.
  • HACs enable the expression of large human transgenes in animal models.

Conclusions:

  • HAC technology represents a rapidly developing field with significant implications for genetic research.
  • HACs offer a powerful platform for functional genomics, gene therapy, and disease modeling.
  • The ability to express large transgenes in vivo using HACs opens new avenues for studying human genetic diseases in animal models.